Jeffrey Gitt, DO
Neurology · Phoenix, AZNPI 1831370741
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $218,114 of the $275,008 with a category attached, or 79.3%. It is spread thinly across 49 manufacturers, the largest accounting for just 23.2%. Reporting peaked in 2019 at $137,274 and has fallen 99.9% since, to $101 in 2025. Among neurology clinicians in AZ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,004 payments — averaging $273.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biogen$64K
- EMD Serono, Inc.$53K
- AbbVie$40K
- Sanofi$38K
- AstraZeneca$28K
- Genentech USA, Inc.$28K
- plus $23K from 43 others
Across 168 payments — averaging $8834.32 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$674K
- F. Hoffmann-la Roche AG$418K
- Genentech, Inc.$234K
- Sanofi US Services Inc.$68K
- Adamas Pharmaceuticals, Inc.$31K
- Hoffmann-la Roche Limited$22K
- plus $36K from 4 others
What the payments were for
- Consulting fees$13,4965%
- Speaking & faculty fees$218,11479%
- Travel & lodging$18,7287%
- Food & beverage$23,1088%
- Education$1680%
- Gifts$1,3931%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$275,008 in reported general payments places this provider in the 95th percentile of 388 neurology providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other neurology in Phoenix
- Barry HendinPhoenix$2.3M
- Maria OspinaPhoenix$2.1M
- Suraj MuleyPhoenix$1.7M
- Eric ErossPhoenix$778K
- Steve ChungPhoenix$685K
- Marwan SabbaghPhoenix$603K
- Kerry KnievelPhoenix$509K
- Lori TravisPhoenix$406K
- Todd SchwedtPhoenix$273K
- Joshua TobinPhoenix$234K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.